Concepedia

Author

Danilo Galizia

Candiolo Cancer InstituteORCID

Also Known As

D Galizia, D. Galizia, Danilo Galizia, Madoka Furukawa

58

Publications

667

Citations

12

H-Index

22

Concepts

All Affiliations

Candiolo Cancer InstituteUniversity of TurinIstituti di Ricovero e Cura a Carattere ScientificoAzienda Sanitaria Ospedaliera S.Croce e Carle Cuneo
DG

About

Danilo Galizia is an author at Candiolo Cancer Institute specializing in cancer research, oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

69

2

Pathology

2

2

69

3

Gastroenterology

1

1

37

4

Immunology

1

1

32

5

Risk

1

1

37

Danilo Galizia

×

9

Publications

308

Citations

9

H-Index

YearCitations

PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models

Ymera Pignochino, Federica Capozzi, Lorenzo D’Ambrosio,

Molecular Cancer

2017

69

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases

Giulia Siravegna, Elena Geuna, Benedetta Mussolin,

ESMO Open

2017

67

Self‐evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study

Danilo Galizia, Andrea Milani, Elena Geuna,

Cancer Medicine

2018

47

Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour

Lorenzo D’Ambrosio, Erica Palesandro, Paola Boccone,

European Journal of Cancer

2017

37

Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression

Matteo Paccagnella, Andrea Abbona, Andrea Michelotti,

Vaccines

2022

32

Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma

Gaetano Apice, Antonio Pizzolorusso, Massimo Di Maïo,

Sarcoma

2016

17

Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide

Marco Merlano, Anna Merlotti, Lisa Licitra,

Clinical and Translational Radiation Oncology

2018

16

MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

Annalisa Petrelli, Sara E. Bellomo, Ivana Sarotto,

ESMO Open

2020

12

Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report

Elisabetta Fenocchio, Ilaria Depetris, Delia Campanella,

BMC Cancer

2016

11

Page 1